Stay updated on Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated software version to v3.2.0, replacing v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T04:49:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T02:54:41.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Core content updated from v3.0.1 to v3.0.2; a minor UI element ('Back to Top') was removed; no changes to pricing, stock, times, or names.
    Difference
    0.2%
    Check dated 2025-09-14T18:52:23.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T13:38:44.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of specific location details such as 'Seoul, South Korea' and the facility name, while also removing previous location terms and references to pembrolizumab and its classifications.
    Difference
    3%
    Check dated 2025-08-31T11:37:04.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:32:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.